FDA panel backs half-dose Moderna booster for older and at-risk US adults
- Advisory panel votes unanimously for lower-dose boosters
- FDA will use panel’s recommendations in making final decision
US health advisers said on Thursday that some Americans who received Moderna’s Covid vaccine should get a half-dose booster to bolster protection against the virus.
The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for Covid.